Directory Last Updated: 20 November 2024
Return to Directory Key Opinion Leaders in Clinical Trials Areas - word selected:- UNKNOWN
Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs.
Page No 1
PhraseConsultantTownSpecial Interests
cancer of unknown primary
*Consultant(s)*
*Towns*Medical oncology, gastrointestinal oncology, lung cancer and mesothelioma, neuroendocrine tumours, cancer of unknown primary, malignant melanoma, kidney cancer
cancer of unknown primary
*Consultant(s)*
*Towns*Medical oncology, upper and lower gastrointestinal cancer, mesothelioma, lung cancer, cancer of unknown primary, neuroendocrine tumours
cancer of unknown primary
*Consultant(s)*
*Towns*Medical oncology, gastrointestinal oncology, mesothelioma, cancer of unknown primary, thoracic cancer, lung cancer
cancer of unknown primary
*Consultant(s)*
*Towns*Medical oncology, breast cancer, cancer of unknown primary, acute oncology
carcinoma of unknown primary
*Consultant(s)*
*Towns*Medical oncology, gastrointestinal oncology, carcinoma of unknown primary, acute oncology
CUP - carcinoma of unknown primary
*Consultant(s)*
*Towns*Medical oncology, bowel and breast cancer, CUP - carcinoma of unknown primary, selective internal radiation therapy - SIRT
MGUS - monoclonal gammopathy of unknown significance
*Consultant(s)*
*Towns*Myeloma, MGUS - monoclonal gammopathy of unknown significance, POEMS, amyloidosis, plasma cell disorders
Page No 1
Spacer

Third Party Advertisement

Adverts by Google